Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by TOUKAN, A. U.
Right arrow Articles by MAYNARD, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOUKAN, A. U.
Right arrow Articles by MAYNARD, J. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 132, No. 2: 220-232
Copyright © 1990 by The Johns Hopkins University School of Hygiene and Public Health


research-article

THE EPIDEMIOLOGY OF HEPATITIS B VIRUS AMONG FAMILY MEMBERS IN THE MIDDLE EAST

ALA U. TOUKAN1, ZIAD K. SHARAIHA2, OMAYMA A. ABU-EL-RUB1, MUNTHER K. HMOUD1, SAED S. DAHBOUR1, HASHEM ABU-HASSAN2, SAMIRA M. YACOUB2, STEPHEN C. HADLER3, HAROLD S. MARGOLIS3, PAT J. COLEMAN3 and JAMES E. MAYNARD3

1Liver Unit, Department of Medicine, Jordan University Hospital Amman, Jordan
2Gastroenterology Section, Department of Medicine, King Hussein Medical Centre Amman, Jordan
3Hepatitis Branch, Division of Viral Diseases, Center for Infectious Disease, Centers for Disease Control Atlanta, GA

In 1985, the authors studied the epidemiology of hepatitis B virus (HBV) in a healthy Middle Eastern population. Residents of three remote villages and urban areas of Jordan were assessed for seroprevalence of hepatitis B surface antigen (HBsAg) and HBV infection. Infection was defined as the presence of antibody to hepatitis B core antigen (total) and/or antibody to hepatitis B surface antigen, with or without HBsAg. The overall HBsAg prevalence was 9.9% and was not age-related, although significant differences were noted between the villages (range, 5.7%–12.8%). The prevalence of HBV infection was 36% and increased with age. In addition, there were differences between the villages in patterns of age-specific infection. A newly constructed socioeconomic index showed greater HBsAg prevalence in lower (14.4%) than in upper (2.4%) socioeconomic groups. A history of contact with a jaundiced person and socioeconomic status were independent risk factors for HBsAg-positive status, while contact with a jaundiced person, rural background, and age were independently related to HBV infection. There was evidence of familial clustering of HBV in two of the villages, with HBV carriers and infected children particularly aggregating around HBsAg-positive siblings. There was also a trend toward an association of HBsAg-positive children with HbsAg-positive mothers. HBV carrier prevalence correlated with family size, and HBV infection in the household Increased proportionately with the number of carriers In the family. Hepatitis B e antigen was detected most frequently in children and antibody to hepatitis B e antigen in adults. Postnatal early childhood transmission through contact among children of poorer and larger families probably accounts for the high endemictty of HBV in this region.

carrier state; family; hepatitis B antibodies; hepatitis B antigens; hepatitis B e antigens; hepatitis B surface antigens; hepatitis B virus; socioeconomic factors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
T. W. Strine, L. E. Barker, A. H. Mokdad, E. T. Luman, R. W. Sutter, and S. Y. Chu
Vaccination Coverage of Foreign-Born Children 19 to 35 Months of Age: Findings From the National Immunization Survey, 1999-2000
Pediatrics, August 1, 2002; 110(2): e15 - 15.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Shibolet, Y. Ilan, S. Gillis, A. Hubert, D. Shouval, and R. Safadi
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers
Blood, June 28, 2002; 100(2): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
E. Regidor, J. L Gutierrez-Fisac, M E. Calle, P. Navarro, and V. Dominguez
Infant mortality at time of birth and cause-specific adult mortality among residents of the region of Madrid born elsewhere in Spain
Int. J. Epidemiol., April 1, 2002; 31(2): 368 - 374.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
F. J. Mahoney
Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection
Clin. Microbiol. Rev., April 1, 1999; 12(2): 351 - 366.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.